• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cell associated urokinase activity and colonic epithelial cells in health and disease.健康与疾病状态下细胞相关的尿激酶活性及结肠上皮细胞
Gut. 1991 Feb;32(2):191-5. doi: 10.1136/gut.32.2.191.
2
Expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in colon disease.
J Clin Lab Anal. 1995;9(6):413-7. doi: 10.1002/jcla.1860090613.
3
Induction of epithelial arachidonate 12-lipoxygenase at active sites of inflammatory bowel disease.炎症性肠病活动部位上皮花生四烯酸12-脂氧合酶的诱导。
Am J Physiol. 1993 Jan;264(1 Pt 1):G104-11. doi: 10.1152/ajpgi.1993.264.1.G104.
4
Urokinase and the intestinal mucosa: evidence for a role in epithelial cell turnover.尿激酶与肠黏膜:上皮细胞更新作用的证据
Gut. 1998 Nov;43(5):656-63. doi: 10.1136/gut.43.5.656.
5
Butyrate is a potent inhibitor of urokinase secretion by normal colonic epithelium in vitro.丁酸盐在体外是正常结肠上皮细胞分泌尿激酶的有效抑制剂。
Gastroenterology. 1994 Aug;107(2):410-9. doi: 10.1016/0016-5085(94)90166-x.
6
Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.尿激酶型纤溶酶原激活剂、尿激酶型纤溶酶原激活剂受体及其抑制剂在春季角结膜炎中的作用
Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1364-70. doi: 10.1167/iovs.04-1196.
7
THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.通过增加尿激酶和尿激酶受体的表达,转化生长因子-β1上调THP-1巨噬细胞膜结合纤溶酶活性。
J Cell Physiol. 1995 Aug;164(2):334-43. doi: 10.1002/jcp.1041640214.
8
Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.尿激酶型纤溶酶原激活剂和基质金属蛋白酶在人结直肠癌中的活性与表达
BMC Cancer. 2006 Aug 18;6:211. doi: 10.1186/1471-2407-6-211.
9
Glucosamine synthetase activity of the colonic mucosa in ulcerative colitis and Crohn's disease.溃疡性结肠炎和克罗恩病中结肠黏膜的氨基葡萄糖合成酶活性
Gut. 1977 Mar;18(3):219-28. doi: 10.1136/gut.18.3.219.
10
Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans.人结肠癌间质细胞中尿激酶型纤溶酶原激活剂的定位
Am J Pathol. 1991 Jan;138(1):111-7.

引用本文的文献

1
Development and Testing of Thrombolytics in Stroke.溶栓药物在中风治疗中的研发与测试。
J Stroke. 2021 Jan;23(1):12-36. doi: 10.5853/jos.2020.03349. Epub 2021 Jan 31.
2
Urokinase-type plasminogen activator deficiency promotes neoplasmatogenesis in the colon of mice.尿激酶型纤溶酶原激活物缺乏促进了小鼠结肠的肿瘤发生。
Transl Oncol. 2014 Apr;7(2):174-187.e5. doi: 10.1016/j.tranon.2014.02.002. Epub 2014 Mar 4.
3
Urokinase and the intestinal mucosa: evidence for a role in epithelial cell turnover.尿激酶与肠黏膜:上皮细胞更新作用的证据
Gut. 1998 Nov;43(5):656-63. doi: 10.1136/gut.43.5.656.
4
Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas.纤溶酶原激活的改变与结直肠腺瘤中上皮细胞发育异常分级相关。
Br J Cancer. 1998;77(2):297-304. doi: 10.1038/bjc.1998.46.
5
Secretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro.正常结肠上皮细胞在体外分泌尿激酶和纤溶酶原激活物抑制剂-1 。
Gut. 1994 Jul;35(7):969-75. doi: 10.1136/gut.35.7.969.
6
General surgery.普通外科
Postgrad Med J. 1991 Oct;67(792):876-91. doi: 10.1136/pgmj.67.792.876.

本文引用的文献

1
Plasminogen activator content of human colon tumors and normal mucosae: separation of enzymes and partial purification.人结肠肿瘤和正常黏膜的纤溶酶原激活物含量:酶的分离与部分纯化
J Natl Cancer Inst. 1980 Aug;65(2):345-51.
2
Antigens of the basement membrane and the peritumoral stroma in human colonic adenocarcinomas: an immunofluorescence study.人结肠腺癌中基底膜和肿瘤周围基质的抗原:一项免疫荧光研究。
Int J Cancer. 1982 Jul 15;30(1):13-20. doi: 10.1002/ijc.2910300104.
3
Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.纤溶酶原激活剂(尿激酶)、纤溶酶和凝血酶对基底膜糖蛋白和胶原成分的影响。
Cancer Res. 1981 Nov;41(11 Pt 1):4629-36.
4
A sensitive, coupled assay for plasminogen activator using a thiol ester substrate for plasmin.
Ann N Y Acad Sci. 1981;370:617-26. doi: 10.1111/j.1749-6632.1981.tb29768.x.
5
Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomas.正常人乳腺和结肠以及乳腺癌和结肠癌中纤溶酶原激活剂的特性研究。
Int J Cancer. 1984 Sep 15;34(3):295-302. doi: 10.1002/ijc.2910340302.
6
The colonic epithelium in ulcerative colitis: an energy-deficiency disease?溃疡性结肠炎中的结肠上皮:一种能量缺乏性疾病?
Lancet. 1980 Oct 4;2(8197):712-5. doi: 10.1016/s0140-6736(80)91934-0.
7
Glycoprotein composition of colonic mucosa. Specific alterations in ulcerative colitis.结肠黏膜的糖蛋白组成。溃疡性结肠炎中的特异性改变。
Gastroenterology. 1984 Nov;87(5):991-8.
8
Plasminogen: purification from human plasma by affinity chromatography.纤溶酶原:通过亲和色谱法从人血浆中纯化。
Science. 1970 Dec 4;170(3962):1095-6. doi: 10.1126/science.170.3962.1095.
9
Fibrinolysis associated with oncogenic transformation. Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration.与致癌转化相关的纤维蛋白溶解。纤溶酶原对细胞形态、琼脂中集落形成及细胞迁移相关变化的需求。
J Exp Med. 1973 Nov 1;138(5):1056-64. doi: 10.1084/jem.138.5.1056.
10
Isolation of plasma membrane from human blood monocytes. Subcellular fractionation and marker distribution.从人血单核细胞中分离质膜。亚细胞分级分离及标志物分布。
Eur J Biochem. 1985 Mar 1;147(2):409-19. doi: 10.1111/j.1432-1033.1985.tb08765.x.

健康与疾病状态下细胞相关的尿激酶活性及结肠上皮细胞

Cell associated urokinase activity and colonic epithelial cells in health and disease.

作者信息

Gibson P R, van de Pol E, Doe W F

机构信息

Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Victoria, Australia.

出版信息

Gut. 1991 Feb;32(2):191-5. doi: 10.1136/gut.32.2.191.

DOI:10.1136/gut.32.2.191
PMID:1650741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1378807/
Abstract

It is not known if urokinase-type plasminogen activator (uPA) is associated with normal colonic epithelial cells. The aims of this study were to determine if normal colonic epithelial cells have uPA activity and whether this is concentrated at the cell membrane. In addition, the contribution of colonic epithelial cell associated uPA activity to disease related pertubations of mucosal uPA activity were examined. A highly enriched population of colonic epithelial cells was isolated from resected colon or biopsy specimens by an enzymatic technique. uPA activity was measured in cell homogenates by a specific and sensitive colorimetric method and expressed relative to cellular DNA. In two experiments subcellular fractionation of colonic epithelial cells was performed by nitrogen cavitation followed by ultracentrifugation over a linear sucrose gradient. The fractions collected were analysed for uPA and organelle-specific enzyme activities. Normal colonic epithelial cells have cell associated uPA activity (mean (SEM) 5.6 (1.1) IU/mg, n = 18). This colocalised with fractions enriched for leucine-beta-naphthylamidase and 5'-nucleotidase, markers of plasma membrane. uPA activities in epithelial cells from cancerous colons (9.8 (3.1) n = 7) or from mucosa affected by inflammatory bowel disease (3.8 (0.7) n = 15) were not significantly different from normal (paired t test), while that in epithelial cells from greatly inflamed mucosa was similar to that from autologous normal or mildly inflamed areas (4.4 (1.2) v 5.9 (3.6), n = 9). Thus normal colonic epithelial cells have cell associated uPA activity which is concentrated on the plasma membranes, suggesting the presence of uPA receptors. Increased mucosal levels of uPA previously reported in patients with inflammatory bowel disease are not due to increased colonic epithelial cell associated uPA.

摘要

目前尚不清楚尿激酶型纤溶酶原激活剂(uPA)是否与正常结肠上皮细胞有关。本研究的目的是确定正常结肠上皮细胞是否具有uPA活性,以及这种活性是否集中在细胞膜上。此外,还研究了结肠上皮细胞相关的uPA活性对与疾病相关的黏膜uPA活性扰动的影响。通过酶技术从切除的结肠或活检标本中分离出高度富集的结肠上皮细胞群体。采用特异性灵敏的比色法测定细胞匀浆中的uPA活性,并以细胞DNA为参照进行表达。在两项实验中,通过氮气空化法对结肠上皮细胞进行亚细胞分级分离,然后在线性蔗糖梯度上进行超速离心。对收集的各组分进行uPA和细胞器特异性酶活性分析。正常结肠上皮细胞具有与细胞相关的uPA活性(平均值(标准误)为5.6(1.1)IU/mg,n = 18)。这与富含亮氨酸-β-萘胺酶和5'-核苷酸酶(质膜标志物)的组分共定位。癌性结肠上皮细胞(9.8(3.1),n = 7)或炎症性肠病累及黏膜的上皮细胞(3.8(0.7),n = 15)中的uPA活性与正常细胞无显著差异(配对t检验),而严重炎症黏膜上皮细胞中的uPA活性与自体正常或轻度炎症区域的相似(4.4(1.2)对5.9(3.6),n = 9)。因此,正常结肠上皮细胞具有与细胞相关的uPA活性,且该活性集中在质膜上,提示存在uPA受体。先前报道的炎症性肠病患者黏膜中uPA水平升高并非由于结肠上皮细胞相关uPA增加所致。